A bacterial protein promotes the recognition of the Legionella pneumophila vacuole by autophagy by Abu Khweek, Arwa
Eur. J. Immunol. 2013. 43: 1333–1344 Innate immunityDOI: 10.1002/eji.201242835 1333
A bacterial protein promotes the recognition of the
Legionella pneumophila vacuole by autophagy
Arwa A. Khweek1,2, Kyle Caution1,2, Anwari Akhter1,2, Basant A.
Abdulrahman1,2,3, Mia Tazi1,2, Hoda Hassan1,2, Neal Majumdar1,2,
Andrew Doran1,2, Evelyn Guirado1,2, Larry S. Schlesinger1,2, Howard
Shuman4 and Amal O. Amer1,2
1 Department of Microbial Infection and Immunity, Center for Microbial Interface Biology,
Columbus, OH, USA
2 Department of Internal Medicine, College of Medicine, and The Ohio State University,
Columbus, OH, USA
3 Department of Biochemistry and Molecular Biology Faculty of Pharmacy, Helwan University,
Cairo, Egypt
4 The University of Chicago, Chicago, IL, USA
Legionella pneumophila (L. pneumophila) is an intracellular bacterium of human alveolar
macrophages that causes Legionnaires’ disease. In contrast to humans, most inbred
mouse strains are restrictive to L. pneumophila replication. We demonstrate that
autophagy targets L. pneumophila vacuoles to lysosomes and that this process requires
ubiquitination of L. pneumophila vacuoles and the subsequent binding of the autophagic
adaptor p62/SQSTM1 to ubiquitinated vacuoles. The L. pneumophila legA9 encodes for an
ankyrin-containing protein with unknown role. We show that the legA9 mutant replicate
in WT mice and their bone marrow-derived macrophages. This is the first L. pneumophila
mutant to be found to replicate in WT bone marrow-derived macrophages other than
the Fla mutant. Less legA9 mutant-containing vacuoles acquired ubiquitin labeling and
p62/SQSTM1 staining, evading autophagy uptake and avoiding lysosomal fusion. Thus,
we describe a bacterial protein that targets the L. pneumophila-containing vacuole for
autophagy uptake.
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Introduction
Legionella pneumophila, the causative agent of Legionnaires’ dis-
ease, is a intracellular pathogen that replicates within human
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alveolar macrophages [1]. Upon internalization by human
macrophages, L. pneumophila disrupts normal endocytic pathway
trafficking to establish a replicative vacuole, this specialized niche
allows the bacterium to multiply exponentially [1, 2]. In contrast
to human, most inbred mice strains are restrictive to L. pneu-
mophila replication [3–7]. Autophagy is among various mecha-
nisms that restrict L. pneumophila growth [5–9]. Autophagy is a
lysosomal degradation pathway that maintains cellular homeosta-
sis by degradation of the cell’s internal components in response
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to starvation and stress [10, 11]. Further, autophagy contributes
to the control of variety of bacterial infections [12–16]. Central
to this pathway is formation of the autophagosome, a double
membrane sac-containing the sequestered cytoplasmic mate-
rial. Atg8-microtubule-associated protein1 light chain 3 (LC3)
is the hallmark of autophagosome formation [12, 17–19].
Autophagolysosomes are generated by fusion of autophago-
somes and lysosomes, where the sequestered cargo is degraded
[8, 11, 12]. Autophagic clearance of protein aggregates requires
ubiquitin-binding proteins such as p62/SQSTM1 [20, 21]. Using
separate domains, p62 binds ubiquitin and LC3, therefore deliv-
ering ubiquitinated targets to the autophagosome for degradation
[11,21].
The genome of L. pneumophila contains several genes pre-
dicted to encode homologous eukaryotic-like protein domains and
some of them have been implicated in L. pneumophila patho-
genesis [22–24]. Ankyrin proteins are distributed within the
nucleus and cytoplasm of eukaryotic cells, and play an essen-
tial role in cell cycle, motility, oncogenesis, and transcriptional
regulation [25–27]. LegA9 was identified among other L. pneu-
mophila eukaryotic-like genes in a bioinformatics screen of the
L. pneumophila Philadelphia-1 genome and encodes for an
ankyrin-containing protein [28]. However, the role of LegA9 in
L. pneumophila pathogenesis is not known.
Here we show that in the restrictive bone marrow-derived
macrophages (BMDMs), the legA9 mutant replicates substantially.
This is the first L. pneumophila mutant to be found to replicate
in WT BMDMs other than the Fla mutant. In contrast to WT,
legA9 mutant vacuoles showed significant reduction in ubiqui-
tin labeling and colocalization with p62, thereby avoiding uptake
by autophagosomes, and enabling intracellular growth. Our data
support a mechanism whereby LegA9 facilitates recruitment of
the autophagic machinery to L. pneumophila vacuoles result-
ing in clearance of infection. This study provides a mechanis-
tic link between LegA9 and clearance of L. pneumophila in WT
macrophages by autophagy.
Results
WT mice are restrictive to parent L. pneumophila
replication but permissive to legA9 mutant strain
To characterize the role of LegA9 in L. pneumophila pathogenesis,
we examined the intracellular replication of the JR32 and legA9
mutant in WT BMDMs. In contrast to the restriction of JR32 in
WT macrophages, the legA9 mutant showed a tenfold increase
in the CFUs over time (48–72 h) (Fig. 1A). Complementation of
legA9 mutation on LegA9 + LegApBC-KS+ plasmid (PL) restricted
the replication of this strain in a comparable manner to JR32
in the presence of Isopropyl β-D-1-thiogalactopyranoside (IPTG)
(Fig. 1B).
Since Legionnaires’ disease is caused by replication of L. pneu-
mophila in alveolar macrophages [1,29], we investigated the role
of LegA9 for bacterial replication within the lungs of live mice.
C57BL/6 mice were infected with 1 × 106 JR32 or the legA9
mutant intratracheally [5]. CFUs after 4 h of infection denoted
the initial bacterial load in the lungs (Fig. 1C); whereas the lungs
of infected mice harbored threefold more legA9 mutant bacteria
compared with the JR32 strain 48 h postinfection (Fig. 1D).
Flagellin mediates restriction of L. pneumophila in murine
macrophages and flaAmutant bacteria replicate significantly more
than the parent strain [5]. Western blot analysis of legA9 mutant
bacterial lysate shows that it contains flagellin comparable to WT
(Supporting Information Fig. 1A). Furthermore, the legA9 mutant
bacteria express a functional Dot/Icm system as shown by the
normal lysis of sheep RBCs (Supporting Information Fig. 1B).
Together, these data indicate that LegA9 plays a role in restricting
L. pneumophila infection in vitro and in vivo.
The legA9 mutant replicates substantially in human
monocyte-derived macrophages
Human are permissive to L. pneumophila replication [30]. To char-
acterize the role of LegA9 in the intracellular replication of L. pneu-
mophila in human, we tested the intracellular growth of JR32
and legA9 mutant in acute monocytic leukemia cell line (THP-1).
THP-1 derivedmacrophages are permissive to parental strain JR32
and were more permissive to legA9 mutant at 48 and 72 h postin-
fection (Supporting Information Fig. 2A). In addition, we evalu-
ated the intracellular growth of legA9mutant in human monocyte-
derived macrophages (hMDMs). The legA9 mutant replicated a
100-fold more than JR32 in hMDMs (Supporting Information
Fig. 2B). Therefore, both JR32 and legA9 mutant replicated in
hMDMs yet, legA9 mutant replicated significantly more than the
JR32 strain.
Vacuoles harboring legA9 bacteria evade fusion with
lysosomes and recognition by autophagy in BMDMs
It is possible that the legA9 mutant replicated in WT macrophages
because it evaded lysosomal fusion [8,9,31]. Thus, we examined
the colocalization of JR32 and legA9 mutant-containing vacuoles
with lysotracker red, a dye that stains acidic compartments in live
cells and is retained after aldehyde fixation (Fig. 2A). Approxi-
mately, 60%of JR32 bacteriawere delivered to lysotracker-labeled
compartments within 1 h of infection. In contrast, only ∼30% of
legA9 mutant bacteria colocalized with lysotracker-labeled com-
partments even at 6 h postinfection (Fig. 2B). Therefore, vacuoles-
containing legA9 mutant bacteria evade lysosomal fusion.
In restrictive murine macrophages, autophagic machinery rec-
ognizes the L. pneumophila phagosome as cargo [8, 32, 33].
Autophagosomes harboring L. pneumophila fuse with lysosomes
and within the autophagolysosome, L. pneumophila is degraded
and the infection is contained [8]. It is possible that legA9-
containing vacuoles escape recognition by the autophagy machin-
ery and therefore are not delivered to lysosomes for degradation.
Consequently, acquisition of endogenous autophagy marker LC3
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Figure 1. WT mice and their BMDM are restric-
tive to parent L. pneumophila intracellular repli-
cation but permissive to legA9 mutant strain.
(A) BMDMs were infected with L. pneumophila
JR32 or the legA9 mutant with MOI of 0.5. CFUs
were scored at 1, 24, 48, and 72 h. (B) BMDMs
were infected with JR32 or the legA9mutant har-
boring empty PL, or legA9+ legA9 pBC-KS+ PL.
(A, B) Data are presented as means ± SD of at
least three independent experiments. Asterisks
indicate significant differences, (*p < 0.05, **p <
0.01, ***p < 0.001; two-tailed t-test). Four female
C57BL/6 mice/group received 1 × 106 of JR32
or legA9 mutant bacteria intratracheally. Lungs
were homogenized and plated for CFUs counting
at (C) 4 or (D) 48 h postinfection. (C, D) Data are
shown as mean + SD of n = 4 and are represen-
tative as one of two independent experiments.
Asterisks indicate significant differences (**p <
0.01 two-tailed t-test).
by JR32 or legA9-containing vacuoles was examined. In contrast to
JR32, legA9-containing vacuoles showed less colocalization with
LC3 (Fig. 2C and D). Approximately 55% of JR32-containing vac-
uoles acquired LC3 staining; whereas ∼30% of legA9-containing
vacuoles acquired the autophagy marker. Together, legA9 mutant
vacuoles evade the recognition by autophagy and lysosomal fusion
resulting in growth in murine macrophages.
Rapamycin increases LC3 acquisition by the legA9
vacuole and restricts its intracellular replication
The above data suggested that the legA9-containing vacuoles are
not recognized as readily as the parent strain as autophagic cargo
for lysosomal delivery. Accordingly, we determined the effect of
autophagy induction on trafficking of legA9-containing vacuoles
[8, 34]. Rapamycin inhibits the mammalian target of rapamycin
pathway and has been used to stimulate autophagy [35]. BMDMs
were pretreated with rapamycin for 1 h prior to infection with
JR32 and legA9 mutant. CFUs enumerated at 1 h (Fig. 3A)
denote equal initial inocula. Induction of autophagy by rapamycin
resulted in a significant decrease in the CFUs of the legA9 mutant
as compared with nontreated macrophages at 24 h (Fig. 3B).
The decrease in bacterial number is not a result of rapamycin or
DMSO-mediated toxicity (Supporting Information Fig. 3). Further-
more, rapamycin treatment increased colocalization of the legA9-
containing vacuoles with lysotracker (Fig. 3C) and LC3 (Fig. 3D)
at 2 h postinfection. To confirm the role of autophagy in L. pneu-
mophila pathogenesis, we examined the effect of bafilomycin, an
inhibitor of lysosomal acidification, on L. pneumophila replication.
Our data demonstrate that bafilomycin treatment resulted in an
increase in JR32 CFUs 72 h postinfection (Supporting Information
Fig. 4). Moreover, 3-methyladenine, an inhibitor of PI3 kinases
increased JR32 CFUs 24 h postinfection (Supporting Information
Fig. 5). Therefore, drugs that induce or inhibit autophagy modu-
late the ability of L. pneumophila to replicate within macrophages.
To further confirm the role of autophagy in controlling L. pneu-
mophila infection in macrophages, we compared the growth rate
of JR32 in WT and Atg5−/− derived BMDMs. Atg5 is an essential
molecule required for autophagy [10], and functions as an essen-
tial mediator of LC3-I to LC3-II conversion [19]. Atg5−/− cells are
unable to execute autophagy as a result of a defect in autophago-
some formation [19]. Both the JR32 and legA9 mutant CFUs were
higher at 72 h (Fig. 4A). These data suggest that a defect in
autophagy in the Atg5−/− mice compromised the clearance of
L. pneumophila. We confirmed the lack of Atg5 in the Atg5−/−
macrophages by Western blot (Fig. 4B). Furthermore, treatment
of infected Atg5−/− BMDMs with JR32 or the legA9 mutant with
rapamycin did not alter the bacterial number at 1 h (Supporting
Information Fig. 6A and C) or 24 h (Supporting Information Fig.
6B and D) postinfection. These data suggest that rapamycin is not
able to induce autophagy in the absence of the essential autophagy
protein Atg5.
It is possible that LegA9 exert its effect locally on L. pneu-
mophila vacuole or globally affecting autophagy throughout the
macrophages. To differentiate between these possibilities, we
infected WT macrophages with the JR32 and legA9 mutant bac-
teria and examined the endogenous LC3-I conversion to LC3-II
by western blotting before and after rapamycin treatment.
Rapamycin-induced autophagy as determined by increase in the
level of LC3-II in 2, and 4 h postinfection in both JR32 and
legA9 infected macrophages (Supporting Information Fig. 7A).
Despite the induction of autophagy by rapamycin in both JR32
and legA9 infected cells, there were no difference in the level of
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Figure 2. Vacuoles harboring legA9mutant bac-
teria significantly evade fusion with lysosomes
and escape recognition by autophagy in WT
BMDMs. (A) Representative images from 6 h
infected WT BMDMs with JR32 or legA9 mutant
bacteria. Nuclei were stained blue with DAPI
and L. pneumophila stained green with L. pneu-
mophila antibody. Lyso-tracker red was used to
stain acidified lysosomes. White arrows show
L. pneumophila colocalization with lysotracker.
(B) Percent colocalization of L. pneumophila with
lyso-tracker. (C) Representative images from 6 h
infected WT BMDMs with JR32 or legA9 mutant
bacteria. LC3 is stained red with LC3 antibody.
White arrows show L. pneumophila colocalization
with LC3. (D) Percent colocalization of L. pneu-
mophila with LC3. Hundred bacteria were scored
fromeach coverslips. Imageswere capturedwith
the 60× objective and magnified 3×, scale bar =
10 μm. (A–D) Data are presented as mean + SD
of n = 3 and are representative of three indepen-
dent experiments. Asterisks indicate significant
differences (**p < 0.01, ***p < 0.001; two-tailed
t-test).
LC3-II between the JR32 and the legA9 infected macrophages
(Supporting Information Fig. 7B). These data suggest that
rapamycin-induced autophagy to the same level in both the JR32
and the IegA9 infected macrophages.
Fewer vacuoles-containing the legA9 mutant acquire
ubiquitin compared with vacuoles harboring JR32
Ubiquitinated cargos are delivered to the autophagic machinery
through a variety of adaptor proteins [11, 21, 36]. The speci-
ficity and targeting mechanisms of L. pneumophila-containing
vacuoles by autophagy are yet to be elucidated. L. pneumophila-
containing vacuoles are decorated with polyubiquitinated pro-
teins in murine BMDMs [37, 38]. We hypothesize that
ubiquitination of L. pneumophila vacuoles tags them for
autophagosome uptake. Accordingly, we examined the acquisi-
tion of ubiquitin by vacuoles-containing JR32 or legA9 mutant.
Approximately 70–75% of vacuoles-containing JR32 associated
with ubiquitin in murine BMDMs at all-time points. In contrast,
only 45% of vacuoles-containing legA9 mutant bacteria were asso-
ciated with ubiquitin (Fig. 5A and B). These data indicate that
fewer legA9--containing vacuoles acquire ubiquitin. Since it is pos-
sible that infectionwith the legA9mutant affects the ubiquitination
level within the cell, we examined total ubiquitination via Western
blotting (Supporting Information Fig. 8) and found that the defect
in colocalization of the legA9mutant vacuoles with ubiquitin is not
a consequence of ubiquitin depletion.
To examine the role of the proteosomal pathway is control-
ling L. pneumophila growth, we inhibited proteasome function
with (MG-132). Proteasomal inhibition did not affect CFUs recov-
ered after infection with JR32 and legA9 mutant bacteria at 1 h
(Supporting Information Fig. 9A and C) or 24 h (Supporting Infor-
mation Fig. 9B and D). These data suggest that the proteasomal
pathway is not required for clearance of L. pneumophila in murine
macrophages.
p62/SQSTM1 targets L. pneumophila-containing vacuo-
les to autophagosomes for degradation in WT BMDMs
Vacuoles-containing JR32 readily colocalize with ubiquitin;
whereas the legA9-containig vacuoles do so less frequently. The
selectivity of this process can be mediated via several adaptor
proteins that link ubiquitination to autophagy [20]. Among these
adaptors is the p62/SQSTM1, which is able to bind ubiquitin and
LC3, therefore delivering ubiquitinated targets to the autophago-
some for degradation [11,21,36]. Thus, we examined the colocal-
ization of vacuoles-containing JR32 and legA9 mutant with p62.
The legA9-containing vacuoles colocalize less frequently with p62
C© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu
Eur. J. Immunol. 2013. 43: 1333–1344 Innate immunity 1337
Figure 3. Induction of autophagy in macrophages restricts legA9 mutant replication, and rescues colocalization with LC3 and fusion with
lysosomes. BMDMs were untreated or pretreated with rapamycin (Rap) for 1 h and kept throughout the infection. BMDMs were infected with
L. pneumophila JR32 or the leg A9mutant for (A) 1 or (B) 24 h with an MOI of 0.5. CFUs were scored at these time points. (C, D) Percent colocalization
of L. pneumophila with (C) lyso-tracker and (D) LC3. Hundred bacteria were scored from each coverslips. (A–D) Data are presented as mean + SD of
n = 3 and are representative of three independent experiments. Asterisks indicate significant differences (**p < 0.01; two-tailed t-test).
when compared with the JR32 strain (Fig. 6A and B). It is plausible
that infection with the legA9 mutant results in downregulation of
p62. Therefore, we examined the level of p62 by ELISA in total cell
lysates from BMDMs infected with JR32 or the legA9 mutant for
6 h. The level of p62 increased following infection with JR32 or the
legA9 mutant compared with nontreated macrophages (Fig. 6C).
These results indicate that legA9-containing vacuoles are defective
in colocalization with p62 despite its abundance in macrophages.
To determine if p62 targets L. pneumophila vacuoles for degra-
dation, p62 level was downregulated in murine macrophages with
specific siRNA. Twenty-four hour postnucleofection, macrophages
were infected with the JR32 or the legA9 mutant. Equivalent num-
bers of bacteria were recovered after 1 h of infection (Fig. 6D).
After 24 h of infection, WT BMDMs did not allow L. pneumophila
replication, yet, downregulation of p62 resulted in a significant
increase in CFUs (Fig. 6E). Downregulation of p62 did not result
in an increase in CFUs of the legA9 mutant (Fig. 6F and G). The
downregulation of p62 was confirmed by western blot analysis
of siRNA-treated macrophage with the p62 antibody (Fig. 6H).
Therefore, p62/SQSTM1 targets L. pneumophila-containing vac-
uoles to the autophagosomes to restrict its growth in WT murine
macrophages. NDP52 is another adaptor protein that acts cooper-
atively with other adaptor proteins to drive efficient antibacterial
autophagy of Salomonella, Shigella, and Listeria [39–41]. To exam-
ine the role of NDP52 in delivering L. pneumophila vacuoles to
autophagosomes, we nucleofectedWT BMDMswith siRNA against
NDP52 prior to infection with JR32 or legA9mutant bacteria (Sup-
porting Information Fig. 10). Our data show that downregulation
of NDP52 does not alter CFUs recovered 24 h postinfection.
The permissiveness of BMDMs to legA9 bacteria is
independent of caspase-1 or caspase-7 activation
Caspase-1-mediated caspase-7 activation restricts L. pneumophila
by promoting fusion of L. pneumophila vacuoles with lysosomes
[5, 8, 9]. Replication of the legA9 mutant could be a result of
impaired activation of caspase-1. Casp-1−/− BMDMs allow for
growth of the JR32 strain [6]. Yet, replication of the legA9 mutant
surpassed that of JR32 at 24, 48, and 72 h postinfection (Fig. 7A).
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Figure 4. BMDMs derived from Atg5−/− mice are defective in clear-
ing the WT L. pneumophila and the legA9 mutant. (A) BMDMs derived
from WT and Atg5−/− mice were infected with L. pneumophila JR32 or
legA9 mutant at an MOI of 0.5. Data are shown as mean ± SD of n = 3
and are representative of two independent experiments. Asterisks indi-
cate significant differences (*p < 0.05; two-tailed t-test. (B) Western blot
showing the absence of Atg 5 in the knockout. Data are representative
of three independent experiments.
Caspase-1 activation is associated with cleavage and maturation
of IL-1β. Our data show that there is no significant difference in
the level of IL-1β produced from WT macrophages infected with
JR32 or the legA9 mutant for 24 h (Fig. 7B). To determine if the
replication of legA9 is due to a lack of caspase-1 activation, detec-
tion of the mature subunits of casp-1 was performed by Western
blot. Infection of WT BMDMs with JR32 or the legA9 mutant was
accompanied by caspase-1 activation (Fig. 7C). Taken together,
these data suggest that the ability of the legA9 mutant to replicate
within WT macrophages is independent of caspase-1 activation.
At physiological levels of infection, L. pneumophila activates
caspase-7 in a caspase-1-dependent manner [6]. Caspase-7 acti-
vation during L. pneumophila infection restricts growth by pro-
moting early macrophage death and efficient delivery of the bac-
terium to the lysosome [6, 42]. It was possible that replication
of the legA9 mutant is due to diminished caspase-7 activation.
Therefore, activation of caspase-7 was assessed by Western blot.
The absence of legA9 did not compromise caspase-7 activation in
WT macrophages (Fig. 7D). Therefore, our data demonstrate that
replication of the legA9 mutant occurs irrespective of caspase-1 or
caspase-7 activation.
The permissiveness of BMDMs to legA9 mutant is
independent of host cell death
Early macrophage death terminates the replication cycle of
L. pneumophila and prevents the establishment of infection [43].
It is plausible that the legA9 mutant manipulates the macrophage
life span to maintain replication. Accordingly, the role of LegA9
in induction of cell death was examined. We measured apopto-
sis in the overall population of macrophages by determining the
cytoplasmic apoptosis histone-associated-DNA-fragments at MOI
of 0.5, 1, and 5. Our results demonstrate that infection by JR32
and the legA9 mutant led to comparable cell death at low and high
MOIs (Fig. 8A).
To understand the role of LegA9 in L. pneumophila-mediated
host cell necrosis, we measured the level of lactate dehydrogenase
(LDH) release in culture supernatants of WT BMDMs infected
with JR32 or the legA9 mutant. Our data demonstrated that at
an MOI of 0.5 or 5, comparable LDH is released after 24 h of
infection with JR32 and the legA9 mutant (Fig. 8B). Together,
our data demonstrate that the ability of legA9 to replicate in WT
macrophages is not due to extension of macrophage survival.
Discussion
LegA9 (lpp2058) was identified among L. pneumophila eukaryotic-
like genes in a bioinformatics screen of the L. pneumophila
Philadelphia-1 genome and encodes for an ankyrin-containing
protein with unidentified role [28]. We showed that L. pneu-
mophila lacking legA9 replicate in WT mice and their derived
macrophages.
Several eukaryotic pathways contribute to the restriction of
L. pneumophila growth in WT BMDMs [5–7], among which WT
macrophages efficiently activate autophagy and deliver L. pneu-
mophila vacuoles for lysosomal degradation. However, it is still
unclear what tags the L. pneumophila vacuole for autophagy
uptake.
Our data suggests that LegA9 protein labeled the L. pneu-
mophila vacuole for autophagy uptake but does not alter cellular
autophagy activity since LC3-II is produced upon both JR32 and
legA9 mutant infections. Additionally, rapamycin treatment acti-
vated autophagy in both JR32 and legA9 infected macrophages,
denying a role for LegA9 in autophagy activation.
We showed that ubiquitination of L. pneumophila vacuoles
targets them to autophagy in a process that is dependent upon
recognition of the ubiquitinated vacuoles by the adaptor p62,
thus delivering them to autophagosomes for degradation. In
contrast to JR32, legA9 mutant vacuoles significantly evade
recognition by p62 and autophagosomes thus escaping delivery
to lysosomes. The A/J mouse strain carries a Naip5 allele
(Naip5(A/J)), which renders its macrophages susceptible to L.
pneumophila infection. Interestingly, vacuoles harboring WT
L. pneumophila derived from AJ macrophages exhibits K48
and K63 polyubiquitinated proteins [37, 38]. Generally, lysine
48 conjugated ubiquitin moieties to proteins target them to
proteasomal degradation while lysine 63 modulates protein
activity and trafficking in the cell [44, 45]. Host proteasomal
degradation of Lys48-linked polyubiquitinated proteins, assembled
on the L. pneumophila vacuole generate amino acids required
for intracellular bacterial survival and growth [46]. However,
we showed that ubiquitination of L. pneumophila vacuoles in
restrictive macrophages targets them to autophagy machinery
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Figure 5. Macrophage vacuoles-containing the legA9 mutant have
reduced ubiquitin compared with vacuoles harboring parent L. pneu-
mophila. (A) Representative images from 6 h infected BMDMs with JR32
or legA9 mutant bacteria. Polyubiquitin is stained red. White arrows
show L. pneumophila colocalization with polyubiquitin. (B) Percent colo-
calization of L. pneumophila with polyubiquitin. Hundred bacteria were
scored from each coverslips. Images were captured with the 60× objec-
tive and magnified 3×, scale bar = 10 μm. Data are presented as means
+ SD of n = 3 and are representative of two independent experiments.
Asterisks indicate significant differences (*p < 0.05, **p < 0.01, ***p <
0.01; two-tailed t-test).
for degradation of their contents. Thus ubiquitination can be
useful for the bacteria to provide nutrition within the vacuole but
could also be detrimental by tagging the vacuole for autophago-
some recognition. Thus, it is necessary for L. pneumophila to
delay the maturation of its containing vacuole [8] by inhibiting
autophagy at a specific stage [47]. L. pneumophila express RavZ,
(a cysteine protease that specifically deconjugates Atg8 proteins
from phospholipid membranes, thus inhibiting autophagy) [47].
We think that LegA9 performs functions beyond vacuole tagging
since L. pneumophila lacking legA9 replicates more than the JR32
strain in the Atg5−/− macrophages with defective autophagy
system.
It seems counterintuitive that L. pneumophila would retain
legA9 in the genome, even though it is not required for replica-
tion in Acanthamoeba castellanii. It has been suggested that main-
taining redundant genes may prevent single genetic lesions from
enabling the bacteria to multiply intracellularly [28]. Our study
shows that when L. pneumophila lacks LegA9 it replicates more
efficiently than the parental strain in human macrophages, thus
making the bacterium more pathogenic. Furthermore, cycling of
L. pneumophila through multiple protozoan hosts in the environ-
ment prevents L. pneumophila-host specialization by maintaining
pathways that are required for growth in macrophages and other
hosts. However, growth restriction of L. pneumophila in themurine
model or under laboratory conditions is sufficient to change the
fitness and host range of this bacterium [48]. Restriction of
L. pneumophila replication in murine macrophages by acquisition
of the LegA9 factor could provide an example of selective pres-
sure to increase adaptability of this bacterium to infect different
hosts.
Materials and methods
Bacterial strains
L. pneumophila JR32 [49] and the legA9 mutant [28] were kindly
provided by Dr. Howard Shuman, University of Chicago. L. pneu-
mophila strains were grown as previously described [6,50].
Cell culture and infections
WT mice were purchased from Jackson laboratory. C57BL/6
BMDMs were prepared from the femurs of 5–8-week-old mice
as previously described [6, 7]. Isolation and preparation of
the hMDMs from peripheral blood was carried out as
previously described [50–52]. Acute monocytic leukemia cell
line (THP-1) was maintained as previously described [53].
Infections were performed as previously described [5–7, 53].
The Atg5−/− mice [54] were obtained from Dr. Herbert W.
Virgin from Washington University with permission of Dr. Noboru
Mizushima.
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Figure 6. p62/SQSTM1 targets L. pneumophila-containing vacuoles to the autophagosomes for degradation in WT murine macrophages. (A) Rep-
resentative images from 6 h infected BMDMs with JR32 or legA9 mutant bacteria. P62 is stained red with p62 antibody. White arrows show
L. pneumophila colocalization with p62. (B) Percent colocalization of L. pneumophila with p62. Hundred bacteria were scored from each coverslips.
Images were captured with the 60× objective and magnified 3×, scale bar = 10 μm. (C) BMDMs were infected with JR32 or the legA9 mutant
for 6 h and the level of p62 protein was quantified in cell lysates by ELISA (performed in triplicate and the SD are too small to detect). BMDMs
were nucleofected with scrambled control (sictrl) or siRNA against p62 (sip 62). Twenty-four hours after nucleofection, murine macrophages were
infected with JR32 or legA9 mutant with an MOI of 0.5 for 1 h (D and F) or 24 h (E and G). (H) Western blot analysis showing the downregulation
of p62 at 24 and 48 h postnucleofection. (A–B and D–H) Data are shown as mean + SD of n = 3 and are representative of three independent
experiments. (C) Data are representative of one experiment n = 3. Asterisks indicate significant differences (*p < 0.05, **p < 0.01; two-tailed t-test).
Western blot analysis
A total of 30 μg/mL of protein was loaded on 12% SDS poly-
acrylamide gel and immunoblotted with antibodies that recog-
nize caspase-1, caspase-7 (cell signaling), p62 (Sigma), mono and
polyubiquitinated conjugates, mAb FK2 (Enzo) and LC3 (Sigma).
The α-flaA polyclonal Ab was obtained from Dr. Howard Shuman,
University of Chicago.
The primary antibodies were followed by appropriate sec-
ondary rabbit or mouse antibodies as described in [6,7,53].
In vitro drug treatment of macrophages
Rapamycin (Sigma-Aldrich, R0395) was dissolved in DMSO
(Sigma-Aldrich, D2650) at 1 mg/mL. Rapamycin was used at a
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Figure 7. The permissiveness of BMDMs to legA9mutant bacteria is independent of caspase-1 or caspase-7 activation. (A) Caspase-1 KO (casp-1−/−)
macrophages were infected with L. pneumophila JR32 or legA9 with an MOI of 0.5 for 1, 24, 48, and 72 h. (B) CFUs were measured at the indicated
time points. Levels of IL-1β were detected in supernatants of WT or casp-1−/− BMDMs infected with JR32 or the legA9mutant after 24 h. WT BMDMs
were either not treated (NT) or infected with L. pneumophila JR32 or legA9 mutant bacteria for 2 h. Activation of casp-1 or casp-7 was detected in
cell extracts using (C) casp-1 or (D) casp-7 antibodies, respectively. (A–D) Data are shown as mean ± SD of n = 3 and are representative of three
independent experiments.
concentration of 0.2 μg/mL [8]. Murine macrophages were either
treated or untreated with rapamycin for 1 h before they were
infected. Rapamycin was maintained throughout the infection.
Bafilomycin A1 (sigma) was added 1 h after infection at final
concentration of 12.5 nM. The 3-methyladenine (sigma) was dis-
solved in heated dH2O at 65◦C, added 1 h before infection at a
concentration of 10mMand kept throughout the infection [8]. The
proteasome inhibitor MG-132 (Biovision, Mountain view, CA) was
dissolved in DMSO and maintained throughout the infection [46].
Macrophage cytotoxicity assay
Quantification of apoptosis was performed using the Cell Death
Detection ELISA (Roche Applied Science) to the specification of
the manufacturer. The fold change of macrophage necrosis was
determined by measuring the release of host cell cytoplasmic LDH
using the cytotoxicity detection kit (Roche Applied Science) to the
specification of the manufacturer.
Confocal laser scanning microscopy
Colocalization experiments were performed as previously
described [5–7]. Antibodies against L. pneumophila (Abcam),
Atg8/LC3 (Abgent, Ap1805a), polyubiquitin FK2 (Enzo), or p62
(BD bioscience) were used. Images were captured with the Olym-
pus Fluoview Fv10i.
Contact-dependent hemolysis
A total of 1 × 108 sheep RBCs (sRBCs) were incubated with
L. pneumophila at an MOI of 25 for 3 h, as previously described
[55,56].
Figure 8. Replication of the legA9 mutant is not due
to extended macrophage survival. (A) BMDMs were not
infected (NT) or infected with L. pneumophila JR32 or the
legA9mutant at anMOI of 0.5, 1 or 5 for 24 h. Apoptosiswas
quantified by Photometric enzyme immunoassay analysis
of cytoplasmic (apoptosis) histone-associated-DNA frag-
ments (ELISA). (B) BMDMs were either not treated (NT) or
treated with L. pneumophila JR32 or the legA9mutant at an
MOI of 0.5 or 5 for 24 h. The fold change in LDH releasewas
measured from the overall population of macrophages.
(A–B) Data are shown as mean ± SD of n = 3 and are rep-
resentative of three independent experiments.
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ELISA for p62
A total of 2 ×106 of BMDMs were either un-infected or infected
with JR32 or the legA9 mutant for 6 h. The levels of p62 or IL-1β
were determined by a sandwich ELISA according to the manufac-
tures specification.
siRNA treatment
siRNA treatment was performed using siRNA against P62
(Dharmacon-18412):ACAGAUGCCAGAAUCGGAA,CUGCUCAGG
AGGAGACGAU, GAACAGAUGGAGUCGGGAA,CCAUGGGUUUCU
CGGAUGA. NDP52 (Dharmacon-76815) CAACACAGAGGGUC
AAUAA, CAGAAGAGGACAUCCGGAU, CCAAGGAUGUG-
GAGCGCU A, GAGUUGAGGUGUCCGUGUA, siRNA was nucleo-
fected into primary macrophages using Lonza Nucleofection kit
and Amaxa equipment as we described previously [57].
Statistical analysis
Most experiments were performed at least three indepen-
dent times and yielded similar results unless indicated. Com-
parisons of groups for statistical difference were done using
student’s two-tailed t-test. p-value ≤ 0.05 was considered
significant.
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